SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 19, 2002
Pharmanetics, Inc.
--------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
North Carolina
---------------------------------------------------------
(State or other jurisdiction of incorporation)
0-25133 56-2098302
------------------------------------- ---------------------------------
(Commission file Number) (IRS Employer ID Number)
9401 Globe Center Drive, Morrisville, North Carolina 27560
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 919-582-2600
--------------------------
NA
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
On July 19, 2002, the Registrant issued the press release filed
herewith as Exhibit 99.1.
Item 7. Exhibits
(c) Exhibits
Exhibit No.
-----------
99.1 Press release issued on July 19, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHARMANETICS, INC.
Date: July 19, 2002 /s/ John P. Funkhouser
----------------------
John P. Funkhouser
President and Chief Executive Officer